Publications

Hanganu, A., Bedetti, C., Degroot, C., Mejia-Constain, B., Lafontaine, A. L., Soland, V., … & Monchi, O. (2014). Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson’s disease longitudinally. Brain, 137(4), 1120-1129.

Hanganu, A., Bedetti, C., Jubault, T., Gagnon, J. F., Mejia‐Constain, B., Degroot, C., … & Monchi, O. (2013). Mild cognitive impairment in patients with Parkinson’s disease is associated with increased cortical degeneration. Movement Disorders, 28(10), 1360-1369.

Provost, J. S., Hanganu, A., & Monchi, O. (2015). Neuroimaging studies of the striatum in cognition Part I: healthy individuals. Frontiers in systems neuroscience, 9, 140.

Hanganu, A., Provost, J. S., & Monchi, O. (2015). Neuroimaging studies of striatum in cognition part II: Parkinson’s disease. Frontiers in systems neuroscience, 9, 138.

Monchi, O., Hanganu, A., & Bellec, P. (2016). Markers of cognitive decline in PD: the case for heterogeneity. Parkinsonism & related disorders, 24, 8-14.

Hanganu, A., Bruneau, M. A., Degroot, C., Bedetti, C., Mejia-Constain, B., Lafontaine, A. L., … & Monchi, O. (2017). Depressive symptoms in Parkinson’s disease correlate with cortical atrophy over time. Brain and cognition, 111, 127-133.

Hanganu, A., & Monchi, O. (2016). Structural neuroimaging markers of cognitive decline in Parkinson’s disease. Parkinson’s disease, 2016.

Hanganu, A., Degroot, C., Monchi, O., Bedetti, C., Mejia-Constain, B., Lafontaine, A. L., … & Bruneau, M. A. (2014). Influence of depressive symptoms on dopaminergic treatment of Parkinson’s disease. Frontiers in neurology, 5, 188.